Insight ReportCoronavirus Insights: US Drugstores Step Up; Potential Drug Shortages Could Be a Long-Term Concern Coresight Research March 23, 2020 Reasons to ReadWith the coronavirus continuing to spread globally, we consider its impact in the US drugstore sector. CVS, Rite Aid and Walgreens are adapting their services in response to the shifting landscape. We discuss the initiatives that these major drugstore chains in the US are rolling out to support consumers during the outbreak, including waiving fees and offering innovative, minimal-contact testing services. We also consider the potential challenge of drug shortages in the US over the longer term, due to the nation’s reliance on China in the medicine manufacturing supply chain. Click here to view Coresight Research’s ongoing coverage of the coronavirus outbreak. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Analyst Corner: Controversy Persists Around Price Gouging with Electronic Shelf Labels, with John HarmonAI in Retail: What’s Now and What’s Next—Premium Subscriber Call, November 2025High-Income Consumers’ Financial Sentiment Reaches New Peak: Weekly US Consumer Sentiment, Week 24, 2025—InfographicWeekly US Store Openings and Closures Tracker 2025, Week 32: Claire’s Files for Bankruptcy—Potentially 1,137 Stores To Close
